# What does research show about LL-37 for oral health and disease?

Canonical source: https://retacompare.com/research/what-does-research-show-about-ll-37-for-oral-health-and-disease

Peptide Longevity Q&A · 2026-03-01


    LL-37 is a human antimicrobial peptide that plays a crucial role in oral health by exhibiting broad-spectrum antimicrobial activity and immunomodulatory functions. It is involved in host defense, inflammation modulation, wound healing, and has implications in various oral diseases.

 What the research shows

The narrative review published in Arch Oral Biol explores the molecular characterization and biological functions of LL-37, the only human cathelicidin antimicrobial peptide. The authors conducted a comprehensive literature search across multiple electronic databases, including PubMed, Scopus, and Google Scholar, to gather relevant studies evaluating LL-37's expression, mechanisms of action, and its pathological implications in oral tissues. The review highlights that LL-37 is expressed in various oral tissues, such as the gingival epithelium, salivary glands, and inflammatory cells, indicating its significant role in host defense against microbial challenges.

 Why it matters for longevity

Understanding the role of LL-37 in oral health is essential for longevity as oral diseases can significantly impact overall health and quality of life. The peptide's ability to modulate inflammation and promote wound healing suggests that it may help maintain oral homeostasis, which is vital for preventing systemic diseases linked to oral health. Furthermore, the altered expression of LL-37 in conditions like periodontitis and oral squamous cell carcinoma indicates its potential as a biomarker for early detection and intervention in age-related oral pathologies.

 Key findings at a glance

LL-37 is the only human cathelicidin antimicrobial peptide.

It exhibits broad-spectrum antimicrobial activity in the oral cavity.

LL-37 modulates inflammatory responses and promotes wound healing.

Altered expression of LL-37 is linked to oral diseases such as periodontitis and oral squamous cell carcinoma.

It plays a multifaceted role in oral immunity, integrating antimicrobial and immunomodulatory functions.

 How LL-37 works (background)

LL-37 functions as a critical component of the innate immune system, providing a first line of defense against pathogens in the oral cavity. Its antimicrobial properties allow it to directly combat a wide range of bacteria, fungi, and viruses, thus contributing to oral health. Additionally, LL-37 influences various biological processes, including inflammation modulation, which is crucial for tissue repair and regeneration. The peptide's role in angiogenesis and cellular proliferation further underscores its importance in maintaining oral homeostasis and responding to microbial challenges.

 Safety, caveats, and what we don't yet know

While the review provides valuable insights into LL-37's functions and implications in oral health, it is essential to recognize that the findings are based on a narrative review of existing literature rather than new clinical trials. The research primarily focuses on in vitro and in vivo studies, which may not fully capture the complexities of LL-37's role in human populations. Further research is needed to explore the safety and efficacy of LL-37 in therapeutic applications, as well as its potential implications in other areas of health beyond oral disease.

 Bottom line

LL-37 is a significant antimicrobial peptide in oral health, contributing to host defense, inflammation modulation, and wound healing. Its role in various oral diseases highlights its potential as a diagnostic biomarker and therapeutic target.

 Related questions

 Can LL-37 improve oral wound healing in older adults?

Research suggests that LL-37 promotes wound healing due to its immunomodulatory functions, which could be particularly beneficial for older adults experiencing slower healing processes.

 Does LL-37 have a role in preventing oral diseases with age?

LL-37's antimicrobial properties and its involvement in inflammation modulation indicate that it may help prevent the onset of oral diseases that become more prevalent with age.

 What are the implications of LL-37 in periodontal disease?

Altered expression of LL-37 has been associated with periodontal disease, suggesting its potential as a biomarker for disease progression and a target for therapeutic interventions.

 Source: PubMed · Arch Oral Biol · published 2026-03-01.

## Sources

- PubMed · Arch Oral Biol: https://pubmed.ncbi.nlm.nih.gov/41544412/